| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 05/14/2002 | US6387622 Single measurement quantification of multiple populations of cells in a flow cytometer using multiple ligand-phycobiliprotein or phycobiliprotein-containing dye markers |
| 05/14/2002 | US6387621 Automated analysis of real-time nucleic acid amplification |
| 05/14/2002 | US6387616 Torsin, torsin genes, and methods of use |
| 05/14/2002 | US6387614 Using electrochemical biosensor with liposomes of glycine-terminated diacetylene lipid, acetylferrocenic diacetylene lipid, and glycosphingolipid; drop in current is indicative of specific biomolecular recognition |
| 05/14/2002 | US6387372 Polypeptides from mycrobacterium paratuberculosis |
| 05/14/2002 | US6387371 Specifically binds to an extracellular domain of the her2 receptor in an amount effective to inhibit growth of cancer cells |
| 05/14/2002 | US6387331 Method and apparatus for performing microassays |
| 05/14/2002 | US6387330 Reagents within microtiter trays; dispensers controllably moved by automated means to a dispensing position where a controlled quanitity is transfered to a specified location; avoids cross-contamination, human error |
| 05/14/2002 | US6387329 Use of an array of polymeric sensors of varying thickness for detecting analytes in fluids |
| 05/14/2002 | US6387290 Tangential flow planar microfabricated fluid filter |
| 05/14/2002 | US6387277 Method for removing contaminants from a fluid stream |
| 05/14/2002 | US6387257 Apparatus for screening compound libraries |
| 05/14/2002 | US6387053 Method and apparatus for determining an indicator which is dependent on respiratory data |
| 05/14/2002 | US6387030 Internal adapter with a pellet well for a centrifuge container |
| 05/14/2002 | US6386044 Multi-depth deflectometer and method |
| 05/14/2002 | US6386027 Method and device for measuring z-directional tensile strength of paper or board |
| 05/14/2002 | US6386021 Oxygen sensor heater service bay test |
| 05/14/2002 | US6386014 Energy measurement device for flowing gas using microminiature gas chromatograph |
| 05/14/2002 | CA2248088C Apparatus and method for separating blood samples |
| 05/14/2002 | CA2229011C Explosive detection screening system |
| 05/14/2002 | CA2175228C Apparatus for assaying viscosity changes in fluid samples and method of conducting same |
| 05/14/2002 | CA2131999C Fast response test panel |
| 05/14/2002 | CA2104678C Protein-induced morphogenesis |
| 05/14/2002 | CA2089742C Methods and compositions for early detection and treatment of insulin dependent diabetes mellitus |
| 05/14/2002 | CA2086323C Functionally active selectin-derived peptides and ligand for gmp-140 |
| 05/14/2002 | CA2032907C Hepatitis c assay |
| 05/12/2002 | WO2002097430A1 Sulfuryl fluoride fumigation process |
| 05/10/2002 | WO2002037209A2 System, method, and computer software product for linked window interfaces |
| 05/10/2002 | WO2002037158A2 Cytological imaging systems and methods |
| 05/10/2002 | WO2002037122A2 Sterol glucoside toxins |
| 05/10/2002 | WO2002037121A2 Detection of modified amino acids by mass spectrometry |
| 05/10/2002 | WO2002037120A2 Diagnosis of pre-eclampsia |
| 05/10/2002 | WO2002037119A2 Method of diagnosing a transmissible spongiform encephalopathy |
| 05/10/2002 | WO2002037118A1 Means for detecting pathological transformation of the app protein and their uses |
| 05/10/2002 | WO2002037117A1 Method for analyzing proteins |
| 05/10/2002 | WO2002037116A1 Method for determining folding conditions for recombinant proteins |
| 05/10/2002 | WO2002037115A1 Detection of infectious agents using antigen mimics |
| 05/10/2002 | WO2002037114A1 Agent for detecting cancer's ability to metastasize |
| 05/10/2002 | WO2002037113A2 Clinical and functional validation of targets from disseminated cancer cells |
| 05/10/2002 | WO2002037112A2 Detection of ovarian cancer |
| 05/10/2002 | WO2002037111A2 Continuous-flow homogeneous biochemical assays based on mass spectrometric detection of known ligands |
| 05/10/2002 | WO2002037110A1 Patterned surfaces for bioconjugation and their preparation |
| 05/10/2002 | WO2002037109A2 Detection of binding species with colloidal and non-colloidal structures |
| 05/10/2002 | WO2002037108A1 Reagent and method for detecting substance |
| 05/10/2002 | WO2002037107A1 Surfaces comprising a hydrophilic spacer, covalently bonded to hydrogels |
| 05/10/2002 | WO2002037106A2 Methods for comparitive analysis of carbohydrate polymers |
| 05/10/2002 | WO2002037105A1 Diagnostic kit for schizophrenia |
| 05/10/2002 | WO2002037103A2 Laser scanning cytometry mediated analysis of therapeutic efficacy in tumors |
| 05/10/2002 | WO2002037102A2 Methods for analyzing dynamic changes in cellular informatics |
| 05/10/2002 | WO2002037101A2 A method to determine an engrafting cell dose of hematopoietic stem cell transplant units |
| 05/10/2002 | WO2002037099A1 Method of diagnosing nephropathy |
| 05/10/2002 | WO2002036833A1 Method and kits for detecting hepatitis infected cells |
| 05/10/2002 | WO2002036829A2 Methods of diagnosing, preventing and treating neurological disorders and neuronal injuries |
| 05/10/2002 | WO2002036821A2 Method for the amplification and optional characterisation of nucleic acids |
| 05/10/2002 | WO2002036820A2 Methods for assessing the risk of non-insulin-dependent diabetes mellitus based on allelic variations in the 5'-flanking region of the insulin gene and body fat |
| 05/10/2002 | WO2002036818A2 Method for detecting inhibitors of tumour growth |
| 05/10/2002 | WO2002036811A1 Membrane fractions of 1,2-sn-diacylglycerol-enriched cells |
| 05/10/2002 | WO2002036808A2 Compositions and methods relating to prostate specific genes and proteins |
| 05/10/2002 | WO2002036807A2 Compositions and methods relating to breast specific genes and proteins |
| 05/10/2002 | WO2002036804A2 Method for detecting hematopoietic stem cells |
| 05/10/2002 | WO2002036784A1 Transgenic animals for analysing cyp3a4 cytochrome p450 gene regulation |
| 05/10/2002 | WO2002036772A1 Novel disease-associated gene and use thereof |
| 05/10/2002 | WO2002036770A2 Polymorphic sequences of the human abca1 gene, their uses, detection methods and kits |
| 05/10/2002 | WO2002036763A1 Novel gene overexpressed in heart and skeletal muscle and use tehreof |
| 05/10/2002 | WO2002036761A2 Compositions and methods for the diagnosis of cancer |
| 05/10/2002 | WO2002036741A2 Polynucleotide encoding an activated human t-lymphocyte-derived protein related to ubiquitin conjugating enzyme |
| 05/10/2002 | WO2002036738A2 Affinity maturation by competitive selection |
| 05/10/2002 | WO2002036733A2 Cd36 as a heat shock protein receptor and uses thereof |
| 05/10/2002 | WO2002036632A2 Single nucleotide polymorphisms in nucleic acids encoding human olfactory receptor-like polypeptides |
| 05/10/2002 | WO2002036631A1 Method of screening antiplatelet |
| 05/10/2002 | WO2002036627A2 Interferons, uses and compositions related thereto |
| 05/10/2002 | WO2002036625A2 Prokineticin polypeptides, related compositions and methods |
| 05/10/2002 | WO2002036624A2 Methods, compositions and therapeutic applications relating to fortilin (= translationally controlled tumor protein, tctp) and modulators thereof |
| 05/10/2002 | WO2002036621A1 Medical and diagnostic use of a specific co-activator for human nuclear receptors |
| 05/10/2002 | WO2002036617A2 A recombinant newcastle disease virus nucleoprotein mutant as a marker vaccine |
| 05/10/2002 | WO2002036616A2 Compositions and methods relating to breast specific genes and proteins |
| 05/10/2002 | WO2002036615A2 Methods for producing and improving therapeutic potency of binding polypeptides |
| 05/10/2002 | WO2002036575A1 Tagging compounds and process for use in aida libraries |
| 05/10/2002 | WO2002036166A2 Compositions for stimulating cd45 and thereby suppressing microglial activation associated with alzheimer's disease |
| 05/10/2002 | WO2002036149A2 Methods for obtaining inhibitors of t-cell membrane protein (tirc7) ligand binding and uses thereof |
| 05/10/2002 | WO2002036148A2 Use of death receptor ligands or rip to initiate the non-caspase-dependent cell death and compounds for inhibition of the non-caspase-dependent cell death |
| 05/10/2002 | WO2002036136A2 Compositions and methods for prolonging survival of chilled platelets |
| 05/10/2002 | WO2002036121A1 Use of 1-ebio in the treatment of bipolar disorders |
| 05/10/2002 | WO2002036075A2 Small molecule compositions for binding to hsp90 |
| 05/10/2002 | WO2002036010A1 System for withdrawing blood |
| 05/10/2002 | WO2002035987A2 METHODS FOR IDENTIFYING TREATMENTS FOR NEUROTOXICITY IN ALZHEIMER'S DISEASE CAUSED BY β-AMYLOID PEPTIDES |
| 05/10/2002 | WO2002022859A3 Assessment of ecosystem health by evaluating multiple biomarkers in a nonhuman organism |
| 05/10/2002 | WO2002012443A3 Active nems arrays for biochemical analyses |
| 05/10/2002 | WO2002009641A3 Promyostatin peptides and methods of using same |
| 05/10/2002 | WO2002007645A3 Pregnancy and sex identification test based on saliva or other bodily fluids |
| 05/10/2002 | WO2002004919A3 Method and apparatus for the assay of precious metals |
| 05/10/2002 | WO2002004492A3 Herpes zinc finger motifs |
| 05/10/2002 | WO2001094949A3 Soluble cd1 compositions and uses thereof |
| 05/10/2002 | WO2001093669A3 Compound screens relating to insulin deficiency or insulin resistance |
| 05/10/2002 | WO2001092477A3 Three-dimensional skin model |
| 05/10/2002 | WO2001092337A3 Soluble ctla4 mutant molecules and uses thereof |
| 05/10/2002 | WO2001090304A3 Nucleic acids, proteins, and antibodies |
| 05/10/2002 | WO2001089564A3 Methods for diagnosing and treating hemostatic disorders by modulating p-selectin activity |
| 05/10/2002 | WO2001088116A3 Method of modulating activation of lymphocytes via modulation of pituitary tumor transforming gene, related screeining methods |
| 05/10/2002 | WO2001085993A3 Method for detecting growth hormone variations in humans, the variations and their uses |